NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 132 filers reported holding NOVAVAX INC in Q3 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $392,000 | +321.5% | 713,454 | +778.0% | 0.00% | +100.0% |
| Q3 2017 | $93,000 | +210.0% | 81,263 | +216.4% | 0.00% | +100.0% |
| Q2 2017 | $30,000 | -76.9% | 25,685 | -74.8% | 0.00% | -75.0% |
| Q1 2017 | $130,000 | -59.9% | 101,798 | -60.4% | 0.00% | -69.2% |
| Q4 2016 | $324,000 | -36.7% | 257,380 | +159.5% | 0.01% | -67.5% |
| Q1 2016 | $512,000 | +137.0% | 99,200 | +284.5% | 0.04% | +66.7% |
| Q4 2015 | $216,000 | -37.4% | 25,800 | -47.1% | 0.02% | -72.1% |
| Q3 2015 | $345,000 | – | 48,800 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |